Global Digital Biomarkers Market PR

1. Global Digital Biomarkers Market Growth to be Propelled by Rapid Use of Health-Related Mobile Applications CAGR of ~35% During 2023 – 2035; Finds Kenneth Research Kenneth Research published a report titled “Digital Biomarkers Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global digital biomarkers market in terms of market segmentation by end user, application, component, and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. The global digital biomarkers market is estimated to grow at a CAGR of ~35% over the forecast period, i.e., 2023-2035. The market is segmented by

2. application into cardiovascular, respiratory disorders, sleep & movement disease, diabetes, psychiatric disorders, and others. out of these, the cardiovascular segment is anticipated to hold the largest share over the forecast period owing to the increasing number of people suffering from cardiovascular diseases. Moreover, there are numerous causes for cardiovascular diseases such as excessive alcoholism, high tobacco consumption, and others. For more information’s@https://www.kennethresearch.com/report- details/digital-biomarkers-market/10352517 The global digital biomarkers market is estimated to grow over the forecast period owing to the increasing incidence of mood disorders. Moreover, rapid use of health-related mobile applications is further expected to boost the growth of the market. Geographically, the global digital biomarkers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of them, the market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 on the back of surge in the number of ageing population, rising prevalence of chronic diseases, and rapid adoption of digital health technologies. Furthermore, there has been increasing expenditure on the advanced healthcare infrastructure is further expected to boost the growth of the market in the region. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy,

3. Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report. Rising Adoption of Wearable Devices to Drive the Growth of the Market In the year 2019, there were more than 700 Million connected wearable devices across the globe The behavioral and psychological changes are tracked in the human body through artificial intelligence, and machine learning techniques making the data accessible to the person wearing the devices. Moreover, the wearable devices are continuously monitoring the health of the person through the integration of artificial intelligence providing insight to the patients. Therefore, it is anticipated to increase the growth of the global digital biomarkers market. However, high cost for the digital biomarkers, lack of awareness among people, and sometimes may show inaccurate results are expected to operate as key restraint to the growth of global digital biomarkers market over the forecast period.

4. This report also provides the existing competitive scenario of some of the key players of the global digital biomarkers market which includes company profiling of Amgen Inc., Kinsa Inc., Bayer AG, GlaxoSmithKline plc., Pfizer Inc., AliveCor, Inc., F. Hoffmann-La Roche Ltd., Brainomix, Sonde Health Inc., Takeda Pharmaceutical Company Limited, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global digital biomarkers market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. Request Report Sample@ https://www.kennethresearch.com/sample- request-10352517 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: sales@kennethresearch.com

5. U.S. Phone: +1 313 462 0609